Laparoscopic versus open surgery for rectal neuroendocrine tumors: a multicenter real-world study

Xinyu Zeng,Chengguo Li,Minhao Yu,Rui Zhang,Guole Lin,Maojun Di,Hongxue Wu,Yueming Sun,Zhiguo Xiong,Congqing Jiang,Bin Yu,Shengning Zhou,Yong Li,Xiaofeng Liao,Lijian Xia,Wei Zhang,Weizhong Jiang,Kaixiong Tao
DOI: https://doi.org/10.1186/s12885-024-12711-x
IF: 4.638
2024-08-05
BMC Cancer
Abstract:Background: Owing to the lack of evidence-based medical studies with large sample sizes, the surgical approach for the radical resection of rectal neuroendocrine tumors remains controversial. Methods: We retrospectively collected the medical records of patients with rectal neuroendocrine tumors who underwent radical resection at 17 large tertiary care hospitals in China between January 1, 2010, and April 30, 2022. All patients were divided into laparoscopic and open surgery groups. After propensity score matching to reduce confounders, the postoperative and oncologic outcomes were compared between the groups. Results: We enrolled 174 patients with rectal neuroendocrine tumors who underwent radical surgery. After random matching, 124 patients were included in the comparison (62, laparoscopic surgery group; 62, open surgery group). The laparoscopic surgery group had fewer complications (14.5% vs. 35.5%, P = 0.007) and superior relapse-free survival (P = 0.048). Subgroup analysis revealed that the laparoscopic surgery group had fewer complications (10.9% vs. 34.7%, P = 0.004), shorter postoperative hospital stays (9.56 ± 5.21 days vs. 12.31 ± 8.61 days, P = 0.049) and superior relapse-free survival (P = 0.025) in the rectal neuroendocrine tumors ≤ 4 cm subgroup. Conclusions: Laparoscopic surgery was associated with improved postoperative outcomes and oncologic prognosis for patients with rectal neuroendocrine tumors ≤ 4 cm; it can serve as a safe and feasible option for radical surgery of rectal neuroendocrine tumors.
What problem does this paper attempt to address?